In the past week, SGRY stock has gone up by 5.62%, with a monthly gain of 12.37% and a quarterly surge of 28.38%. The volatility ratio for the week is 4.33%, and the volatility levels for the last 30 days are 4.34% for Surgery Partners Inc The simple moving average for the past 20 days is 4.32% for SGRY’s stock, with a 10.60% simple moving average for the past 200 days.
Is It Worth Investing in Surgery Partners Inc (NASDAQ: SGRY) Right Now?
Moreover, the 36-month beta value for SGRY is 2.76. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 2 as “overweight,” 4 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SGRY is 70.88M and currently, short sellers hold a 15.28% of that float. On September 19, 2024, SGRY’s average trading volume was 1.13M shares.
SGRY) stock’s latest price update
Surgery Partners Inc (NASDAQ: SGRY)’s stock price has plunge by 2.49relation to previous closing price of 31.38. Nevertheless, the company has seen a 5.62% surge in its stock price over the last five trading sessions. zacks.com reported 2024-08-06 that Surgery Partners (SGRY) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.28 per share a year ago.
Analysts’ Opinion of SGRY
Many brokerage firms have already submitted their reports for SGRY stocks, with Macquarie repeating the rating for SGRY by listing it as a “Outperform.” The predicted price for SGRY in the upcoming period, according to Macquarie is $31 based on the research report published on June 28, 2024 of the current year 2024.
Barclays, on the other hand, stated in their research note that they expect to see SGRY reach a price target of $35. The rating they have provided for SGRY stocks is “Equal Weight” according to the report published on March 06th, 2024.
TD Cowen gave a rating of “Outperform” to SGRY, setting the target price at $35 in the report published on November 14th of the previous year.
SGRY Trading at 8.55% from the 50-Day Moving Average
After a stumble in the market that brought SGRY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.88% of loss for the given period.
Volatility was left at 4.34%, however, over the last 30 days, the volatility rate increased by 4.33%, as shares surge +15.48% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +33.67% upper at present.
During the last 5 trading sessions, SGRY rose by +5.62%, which changed the moving average for the period of 200-days by -1.80% in comparison to the 20-day moving average, which settled at $31.04. In addition, Surgery Partners Inc saw 0.53% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SGRY starting from Bradley Owens, who proposed sale 9,241 shares at the price of $30.69 back on Sep 05 ’24. After this action, Bradley Owens now owns shares of Surgery Partners Inc, valued at $283,652 using the latest closing price.
Bane Harrison R., the National Group President of Surgery Partners Inc, sale 6,325 shares at $31.11 during a trade that took place back on Sep 04 ’24, which means that Bane Harrison R. is holding 48,236 shares at $196,742 based on the most recent closing price.
Stock Fundamentals for SGRY
Current profitability levels for the company are sitting at:
- 0.14 for the present operating margin
- 0.21 for the gross margin
The net margin for Surgery Partners Inc stands at 0.0. The total capital return value is set at 0.06. Equity return is now at value -1.70, with -0.48 for asset returns.
Based on Surgery Partners Inc (SGRY), the company’s capital structure generated 0.56 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at 1.26. The interest coverage ratio of the stock is 3.82.
Currently, EBITDA for the company is 526.6 million with net debt to EBITDA at 7.22. When we switch over and look at the enterprise to sales, we see a ratio of 2.53. The receivables turnover for the company is 5.52for trailing twelve months and the total asset turnover is 0.39. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.83.
Conclusion
To wrap up, the performance of Surgery Partners Inc (SGRY) has been better in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
